Delivery Order SPE2DB22D2206-SPE2DB24FEE79

Award Date 11/17/23
Potential Completion Date 11/20/23
Potential Value $6.6K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The federal contract award is for the delivery of Ropinirole HCL ER 2 mg tablets to the Defense Logistics Agency (DLA) by the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The single-award Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Amerisourcebergen Drug Corp is valued at up to $999,999,999.00 and runs through December 2025. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of...
This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,023.78, is for the supply of Ropinirole HCL ER 6 mg tablets. The contract has a performance period through March 31, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award, identified as SPE2DX15D2205|SPE2DX24F74RL, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,235.59, is for the delivery of 90 tablets of the prescription drug Ropinirole HCL ER 2 mg. This is a Firm Fixed Price Delivery Order contract with a completion date of November 24, 2023. The contract was not designated as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $4,745.89, is for the delivery of 500 tablets of the prescription medication Ropinirole Hydrochloride 1 mg. This is a firm fixed-price delivery order contract with a completion date of November 17, 2023. The contract was awarded on November 16, 2023 and was not designated as a set-aside procurement. Amerisourcebergen...
This federal contract award, valued at $111,908.16, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under the company's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999 through November 2026. This IDC serves as a primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical...
This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,691.17 firm fixed-price delivery order is for RYTARY ER 48.75 MG-195 MG CAP 100S, a pharmaceutical product. The contract has an ultimate completion date of November 25, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
The U.S. Defense Logistics Agency (DLA) awarded a $12,990.43 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide a variety of pharmaceutical products and medical supplies. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. Through this IDC, Amerisourcebergen supplies specialty, brand name, generic,...
This federal contract award, valued at $12,354.05, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the drug Rinvoq ER 15 mg tablet, with a completion date of December 11, 2024. The contract type is firm fixed price. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award, valued at $1,195.55, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under the company's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to supply a comprehensive range of pharmaceutical products...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $5,256.57 with a completion date of July 22, 2024. The award was made by the Defense Logistics Agency (DLA), a defense agency, for the procurement of MYRBETRIQ ER 25 MG TABLET 90S, a pharmaceutical product. The contract is a firm fixed-price arrangement and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB24FEE79
    Delivery Order

This federal contract award is for the delivery of Ropinirole HCL ER 6 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The $6,555.90 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. The contract has an ultimate completion date of November 20, 2023 and was awarded on November 17, 2022.

AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities. These IDCs enable efficient government procurement of essential pharmaceutical and medical items, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 5/12/25, 10:25 AM